Kenya introduces twice-yearly HIV prevention shot in Nairobi slum, highlighting systemic health disparities

The introduction of lenacapavir in Nairobi's slums is a significant medical milestone, but it must be contextualized within the broader systemic challenges of health inequity and global health governance.

Indigenous knowledge systems and community-based health models offer valuable insights that are often overlooked in favor of top-down biomedical solutions. Historically, HIV prevention efforts have been shaped by power dynamics that prioritize pharmaceutical innovation over grassroots participation. A cross-cultural perspective reveals the potential of integrating diverse health practices to create more holistic responses. To ensure lenacapavir's success, it must be accompanied by policies that address gender inequality, poverty, and access to healthcare. Future modeling should prioritize community ownership and sustainability, while marginalized voices—particularly those of key populations—must be central to the design and implementation of HIV prevention strategies.